Comparative Pharmacology
Head-to-head clinical analysis: DROSPIRENONE ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM versus ESTROGEL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DROSPIRENONE ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM versus ESTROGEL.
DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM vs ESTROGEL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Combination of drospirenone (a progestin with antimineralocorticoid and antiandrogenic activity), ethinyl estradiol (an estrogen), and levomefolate calcium (a folate supplement). Prevents ovulation by suppressing gonadotropins; increases cervical mucus viscosity, inhibiting sperm penetration; levomefolate provides folate to reduce neural tube defect risk.
Estradiol is a steroid hormone that binds to estrogen receptors (ERα and ERβ), activating gene transcription and non-genomic signaling pathways, leading to proliferation and differentiation of target tissues including breast, endometrium, and bone.
One tablet orally once daily for 28 days (21 active tablets containing drospirenone 3 mg, ethinyl estradiol 0.02 mg, and levomefolate calcium 0.451 mg, followed by 7 placebo tablets containing levomefolate calcium 0.451 mg).
1.25 g (equivalent to 0.75 mg estradiol) applied once daily to upper arm or inner thigh; dose may be increased to 2.5 g (1.5 mg) depending on response.
None Documented
None Documented
Drospirenone: ~30 hours (steady state achieved after 8 days). Ethinyl estradiol: ~13-17 hours (biphasic, terminal). Levomefolate calcium: ~4-6 hours (folate derivatives have longer retention).
The terminal elimination half-life of estradiol after transdermal administration is approximately 10–15 hours, supporting once-daily or twice-weekly dosing regimens. The half-life of estrone (major metabolite) is longer (12–20 hours), contributing to sustained estrogenic effects.
Drospirenone: ~50% renal (as metabolites), ~40% fecal. Ethinyl estradiol: ~40% renal, ~60% fecal. Levomefolate calcium: ~70% renal (as folate metabolites), ~30% fecal.
Estradiol and its metabolites are primarily excreted in urine (≈90%) after conjugation (glucuronide and sulfate) in the liver, with the remainder eliminated in feces (≈10%) via bile. Less than 5% is excreted as unchanged parent drug.
Category D/X
Category C
Progestin + Estrogen
Estrogen